Mark Cuban, founder of Cost Plus Drugs, is sharing access to its application programming interface so that TrumpRx can pull price data, per a healthcaredive.com report. The report added that Cuban ...
DALLAS, Nov. 6, 2025 /PRNewswire/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable ...
Hosted on MSN
'Trying to save everybody money': Giant Eagle and Mark Cuban's Cost Plus Drugs are teaming up
Giant Eagle customers are used to their loyalty card saving them a few bucks, but now there’s a new way to save money at the pharmacy, thanks to Mark Cuban. "We're proud to announce a partnership with ...
The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...
Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s ...
NASHVILLE, TENNESSEE / ACCESS Newswire / December 4, 2025 / GraphiteRx and Mark Cuban Cost Plus Drugs today announced an expansion of their partnership to power the Cost Plus Marketplace for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results